Kallyope uses the science of gut-brain biology to create medicines that transform human health.
Kallyope has raised $8.2M in total funding. The most recent round was Grant. The last funding was announced in May 2023.
Kallyope's investors include Lux Capital, Bill & Melinda Gates Foundation, Illumina Ventures, StepStone Group, Mubadala.
Kallyope is headquartered in New York, United States.
Kallyope uses the science of gut-brain biology to create medicines that transform human health.
Kallyope is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kallyope — Funding & Investors." VCBacked, May 10, 2023, https://www.vcbacked.co/company/kallyope. Accessed August 15, 2026.
VCBacked. (2023). Kallyope — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/kallyope
{{cite web |title=Kallyope — Funding & Investors |url=https://www.vcbacked.co/company/kallyope |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated